Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug.
about
Anti-PEG immunity: emergence, characteristics, and unaddressed questions.PEGylation as a strategy for improving nanoparticle-based drug and gene deliveryUnderstanding the immunogenicity and antigenicity of nanomaterials: Past, present and future.Systemic delivery of blood-brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissueAccelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease.Pharmaceutical and pharmacological approaches for bioavailability enhancement of etoposide.Nanogels: An overview of properties, biomedical applications and obstacles to clinical translationAssessing the effect of a nude mouse model on nanoparticle-mediated gene delivery.Effect of charge ratio on lipoplex-mediated gene delivery and liver toxicity.Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics.Activation of TLR9 by incorporated pDNA within PEG-coated lipoplex enhances anti-PEG IgM production.Cleavable PEGylation: a strategy for overcoming the "PEG dilemma" in efficient drug delivery.Biodistribution and toxicity of orally administered poly (lactic-co-glycolic) acid nanoparticles to F344 rats for 21 days.pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin.Nonadditive Effects of Repetitive Administration of Lipoplexes in Immunocompetent Mice.
P2860
Q26825556-B117C0FC-B2BC-453F-89DA-0E341263CB1FQ36703361-8FEC68E9-FA8F-4C65-A182-7BEB62508A53Q36739647-90C085D7-9C3F-4676-ADD8-F737FDE52CBBQ36881132-46E5A5F9-897F-4A4D-BA62-05AA0F1D0F90Q37123107-94F34CB0-8653-473F-808B-33C547539700Q38185496-5BE70CA0-1A74-474E-91BA-2642F4C4B1BBQ38634048-46F5DCC7-63CC-46C5-A0B9-A80C0D7E9964Q38750076-722ACD8C-8997-49E9-9933-657E1E8671C9Q38816533-DFBD18E2-B908-44F5-8A82-D51D49060999Q41880684-800F5826-D245-4948-AB1E-E4C92026676AQ42227407-9A938523-0E66-42F1-904B-79F4383751E1Q47288830-306BE96F-BBE6-4372-BCA2-13E34B37D4B2Q48653986-F4212A88-2CE7-48FF-BA96-ED7914DACB55Q53091050-FEFCAE2B-364A-413C-B6F6-FFC0CDEF8626Q53662280-C3058677-4C36-4154-923D-874895AFD907
P2860
Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Accelerated blood clearance of ...... encapsulated anticancer drug.
@en
Accelerated blood clearance of ...... encapsulated anticancer drug.
@nl
type
label
Accelerated blood clearance of ...... encapsulated anticancer drug.
@en
Accelerated blood clearance of ...... encapsulated anticancer drug.
@nl
prefLabel
Accelerated blood clearance of ...... encapsulated anticancer drug.
@en
Accelerated blood clearance of ...... encapsulated anticancer drug.
@nl
P2093
P2860
P1476
Accelerated blood clearance of ...... d encapsulated anticancer drug
@en
P2093
Hoorieh Soleimanjahi
Roonak Saadati
Zahra Abbasian
P2860
P304
P356
10.1007/S11095-012-0934-Y
P577
2012-11-27T00:00:00Z